Table 2.
Males |
Females |
Total |
||||
---|---|---|---|---|---|---|
No. | % | No | % | No. | % | |
Age (yrs) | ||||||
13—19 | 15 | 0.4 | 13 | 0.5 | 28 | 0.4 |
20—29 | 51 | 1.2 | 92 | 3.4 | 143 | 2.1 |
30—39 | 450 | 10.6 | 471 | 17.6 | 921 | 13.3 |
40—49 | 1617 | 38.0 | 1025 | 38.3 | 2642 | 38.1 |
50—64 | 1841 | 43.3 | 917 | 34.3 | 2758 | 39.8 |
65+ | 279 | 6.6 | 156 | 5.8 | 435 | 6.3 |
Transmission category | ||||||
Male-to-male sexual contact | 1198 | 28.2 | 0.0 | 1198 | 17.3 | |
Injection drug use | 582 | 13.7 | 244 | 9.1 | 826 | 11.9 |
Male-to-male sexual contact and injection drug use | 113 | 2.7 | 0.0 | 113 | 1.6 | |
High-risk heterosexual contact | 2308 | 54.3 | 2349 | 87.8 | 4657 | 67.2 |
Other | 51 | 1.2 | 82 | 3.1 | 133 | 1.9 |
Total | 4253 | 100.0 | 2675 | 100.0 | 6928 | 100.0 |